Luigi Meneghini
About
In The Last Decade
Luigi Meneghini
110 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Endocrinology, Diabetes and Metabolism 2.6k
- Surgery 990
- Genetics 533
- Molecular Biology 462
- Epidemiology 193
Countries citing papers authored by Luigi Meneghini
This map shows the geographic impact of Luigi Meneghini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Meneghini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Meneghini more than expected).
Fields of papers citing papers by Luigi Meneghini
This network shows the impact of papers produced by Luigi Meneghini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Meneghini. The network helps show where Luigi Meneghini may publish in the future.
Co-authorship network of co-authors of Luigi Meneghini
This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Meneghini. A scholar is included among the top collaborators of Luigi Meneghini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Meneghini. Luigi Meneghini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 10 | |
| 5 | 2 | |
| 6 | 51 | |
| 7 | 1 | |
| 8 | Health status in people with type 2 diabetes on basal-oral therapy is significantly improved with insulin degludec vs insulin glargine | 2 |
| 9 | 98 | |
| 10 | Insulin for intensifying diabetes treatment. | 2 |
| 11 | Insulin degludec in a flexible daily dosing regimen provides similar glycaemic control without increasing rates of hypoglycaemia compared to dosing the same time daily in type 2 diabetes | 6 |
| 12 | Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes | 8 |
| 13 | 14 | |
| 14 | 53 | |
| 15 | 25 | |
| 16 | 43 | |
| 17 | 8 | |
| 18 | 16 | |
| 19 | 1 | |
| 20 | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.